ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

Congress Holds Recision Hearings

February 28, 1975

NAS To Honor Outstanding Scientists

February 28, 1997

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

In Brief: Adjuvant Chemotherapy Standard Practice For Breast Cancer At Milan, Bonadonna Says

May 7, 1976

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

In Brief: Saunders Retires As Dean of UT Graduate School At Galveston; Started Centers Program At NCI

August 21, 1987